03:54 GMT03 March 2021
Listen Live
    Asia & Pacific
    Get short URL

    MOSCOW (Sputnik) - The COVID-19 vaccine by the Pfizer Australia Pty biopharmaceutical company has become the first vaccine to receive regulatory approval in Australia, the Therapeutic Goods Administration (TGA) announced on Monday.

    "The Therapeutic Goods Administration (TGA) has granted provisional approval to Pfizer Australia Pty Ltd for its COVID-19 vaccine, COMIRNATY, making it the first COVID-19 vaccine to receive regulatory approval in Australia. Following a thorough and independent review of Pfizer's submission, the TGA has decided that this vaccine meets the high safety, efficacy and quality standards required for use in Australia," the TGA said in a statement.

    The Australian government expects 10 million doses of the Pfizer/BioNTech vaccine in early 2021. It has also agreed with the AstraZeneca and Navavax pharmaceutical companies on the additional supplies of 20 million and 11 million doses of the manufacturers' COVID-19 vaccines, respectively.

    The provisional approval is said to be valid for two years. The two-dose vaccine will be administered to individuals who are 16 years of age and older, according to the regulator.

    Australia's Department of Health has so far confirmed more than 28,700 cases of COVID-19 since the start of the pandemic, including 909 deaths.

    vaccine, COVID-19, coronavirus, Pfizer, Australia
    Community standardsDiscussion